The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24
Authors:
Anitua E, Sánchez M, Orive G.
Authors:
Anitua E, Sánchez M, Prado R, Orive G.
The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)
Authors:
Anitua E, Alkhraisat MH, Orive G.
Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)
Authors:
Guerra I, Morais Branco F, Vasconcelos M, Afonso A, Figueiral H, Zita R.
Evaluation of implant osseointegration with different regeneration techniques in the treatment of bone defects around implants: an experimental study in a rabbit model.
Clin Oral Implants Res. 2010
Authors:
Gallo I, Sáenz A, Artiñano E, Esquide J.
Autologous platelet-rich plasma: effect on sternal healing in the sheep model.
Interact Cardiovasc Thorac Surg. 2010; 11(3):223-5.
Authors:
Sanchéz M, Anitua E, Andia I.
Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6
Authors:
Orive G, Ali OA, Anitua E, Pedraz JL, Emerich DF.
Novel Biomaterial-based technologies for brain anti-cancer therapeutics.
Biochim Biophys Acta. 2010; 1806(1):96-107
Authors:
López-Jornet P, Camacho-Alonso F, Molina-Miñano F, Vicente-Ortega V.
Effects or plasma rich in growth factor on wound healing of the tongue. Experimental study in rabbits.
Med Oral Patol Oral Cir Bucal 2009; 14 (9): 425-428.
Authors:
Harguindey S, Arranz JL, L. Wahl M, Orive G, J. Reshkin S.
Proton transport inhibitors (pti) as potentially selective anticancer drugs.
Anticancer Research 2009; 29 (6):2127-36
Authors:
Harguindey S, Orive G, Cacabelos R, Hevia EM, Otazu RD, Arranz JL, Anitua E
An integral approach to the etiopathogenesis of human neurodegenerative diseases (hndds) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).
Neuropsychiatry Dis. Treatment. 2008; 4:1073-1084.
Authors:
Harguindey S, Reshkin S, Orive G, Arranz, JL, Anitua E.
Growth and trophic factors, pH and the Na/H exchanger in Alzheimer´s disease, other neurodegenerative diseases and cancer: New therapeutic possibilities and potential dangers.
Curr Alzheimer Dis 2007;4:53-65.
Authors:
Harguindey S, Orive G, et al.
The role of pH dynamics and the Na/H antiporter in the ethiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature.
BBA Cancer Rev 2005;1756:1-24.
Authors:
Orive G., Gascón AR, Hernández RM, Pedraz JL.
The search for new B-cell sources.
Trends Biotechnology 2004; 22: 612-613
Authors:
Orive G., Hernández RM, Gascón AR, Domínguez-Gil A, Pedraz JL
New approaches in the delivery of biopharmaceuticals
Trends Pharmacological Sci 2004; 25: 382-387
Authors:
Orive G., Reshkin S.J., Harguindey S., Pedraz J.L.
Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis
British J Cancer 2003; 89: 1395-1399
Authors:
Orive G., Hernández R., Gascón A.R., Igartua M., Pedraz J.L.
A glimmer of hope for diabetics?
Trends Biotechnology 2003; 21 (7): 289-290.
Authors:
Orive G., Hernández RM, Gascón AR, Igartua M, Pedraz JL
Controversies over stem cell research.
Trends Biotechnology 2003; 21: 109-112.
Authors:
Orive G, Hernández R, Gascón A.R., Calafiore R, Chang T.M.S., De Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro A.M.J., Pedraz J.L.
Cell microencapsulation: promise and progress.
Nature Medicine 2003; 9: 104-107
Authors:
Murua A, Orive G, Hernández RM, Pedraz JL
Emerging technologies in the delivery of erythropoietin for therapeutics.
[ See Abstract ]Med Res Rev. 2011; 31(2):284-309